Mitochondrial Hypermetabolism in the Hippocampus Signals Early Alzheimer’s Changes
Summary: Researchers from Karolinska Institutet report a previously unrecognized early phase in Alzheimer’s disease: a temporary increase in mitochondrial metabolism in the hippocampus. In mice engineered to develop Alzheimer-like pathology, the team observed a metabolic boost that precedes synaptic disruption caused by impaired cellular recycling (autophagy). These results point to metabolic shifts as potential early diagnostic markers and targets for timely intervention.
Key facts
- An early indicator of Alzheimer’s disease is increased metabolic activity in the hippocampus.
- Metabolic alterations appear before the characteristic insoluble amyloid plaques accumulate.
- Disruption of autophagy at synapses follows the metabolic change and contributes to synaptic disorganization.
Source: Karolinska Institute
Overview
Alzheimer’s disease is the most common form of dementia and affects many thousands of people annually. The new study identifies a distinct early event in disease progression: mitochondrial hypermetabolism in the hippocampus, the brain region crucial for short-term memory and one of the first areas affected in Alzheimer’s. Using time-course analyses in App knock-in mouse models that reproduce key aspects of human amyloid pathology, the researchers show that altered energy metabolism is among the earliest detectable molecular changes.
The research team combined transcriptome profiling of hippocampal tissue with functional studies of isolated mitochondria, ultrastructural analysis by electron microscopy, and other methods to map the sequence of events. Transcriptomic time-course data revealed that energy metabolism pathways are significantly upregulated at an early disease stage. Functional tests confirmed increased oxidative phosphorylation driven by mitochondrial complexes I, IV and V. This heightened activity was associated with greater vulnerability to oxidative damage and calcium overload.
As pathology progressed in the older mice, the brain shifted from this early hypermetabolic state to hypometabolism, with a reduced abundance of mitochondria at presynaptic terminals. At later stages, synapses displayed structural changes: enlarged presynaptic areas, abnormal accumulation of synaptic vesicles, and an increase in autophagosomes. The autophagosome buildup indicated local impairment of autophagy—the cell’s protein and organelle recycling mechanism—disrupting access to functioning proteins and contributing to synaptic disorganization.
These findings show a clear temporal sequence: early mitochondrial hyperactivity, then impaired autophagy at synapses, followed by synaptic degeneration and later metabolic decline. Identifying metabolic changes that occur well before plaque accumulation raises the possibility of new early-detection strategies and therapeutic approaches aimed at stabilizing mitochondrial and autophagic function.
Implications and next steps
Because Alzheimer’s disease begins to develop decades before clinical symptoms appear, detecting early molecular changes is crucial for effective intervention. The authors suggest that monitoring metabolic markers in the hippocampus could aid earlier diagnosis and selection of patients for treatments that slow disease progression. Ongoing work in the research groups will further probe the roles of mitochondria and autophagy using additional mouse models that more closely mirror human Alzheimer’s pathology. Planned experiments include testing candidate molecules that support mitochondrial function and normalize autophagy to evaluate whether such interventions can delay or prevent synaptic decline.
Quotes
Per Nilsson, Associate Professor at the Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, emphasizes the need for early detection: “The disease starts to develop 20 years before the onset of symptoms, so it’s important to detect it early—especially given the disease-modifying drugs that are beginning to arrive. Metabolic changes can be a diagnostic factor.”
Maria Ankarcrona, Professor at the same department, adds: “It is notable that metabolic changes occur before the characteristic insoluble plaques have accumulated in the brain. These early energy alterations align with imaging studies of the Alzheimer brain, but our work detects them at an earlier stage.”
Funding and disclosures
The study was funded by grants from the Swedish Research Council, the Swedish Alzheimer’s Foundation and the Swedish Brain Fund, along with private donations. The researchers reported no conflicts of interest.
About this Alzheimer’s disease research news
Author: Per Nilsson
Source: Karolinska Institute
Contact: Per Nilsson – Karolinska Institute
Image credit: Neuroscience News
Abstract (summary)
The study titled “Mitochondrial hypermetabolism precedes impaired autophagy and synaptic disorganization in App knock-in Alzheimer mouse models” examined AppNL-F and AppNL-G-F knock-in mice using time-course transcriptome analysis of hippocampus. Early-stage pathology was characterized by upregulated energy metabolism and increased oxidative phosphorylation in mitochondria, which led to greater susceptibility to oxidative stress and calcium overload. As disease progressed, the hippocampus transitioned to hypometabolism, with fewer mitochondria at presynaptic sites and local autophagy impairment marked by accumulated autophagosomes. These changes culminated in synaptic disorganization. The work refines our temporal understanding of Alzheimer’s-related pathologies and supports exploring therapies that stabilize mitochondrial and autophagic pathways.